![]() ![]() Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance. Competitive and/or technological threats are highlighted. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Recent developments in the company covered in the profile help you track important events.Įquip yourself with information that enables you to sharpen your strategies and transform your operations profitably. The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Stay up to date on the major developments affecting the company. Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. You get detailed information about the company and its operations to identify potential customers and suppliers. Key benefits of buying this profile include: Jan 11,2019: Gedeon Richter announces Executive Management changes May 29,2019: Molecular Biology Laboratory inaugurated in the Hungarian city of Debrecen Richter Gedeon Nyrt Key Recent Developments Richter is headquartered in Budapest, Hungary. The company has a research and development unit in Central Eastern Europe. It operates sales network in Hungary, Central Eastern Europe and the Commonwealth of Independent States (CIS) countries. Richters research activities focus exclusively on the development of original small molecules, recombinant biotechnology and generic product development. The companys product portfolio consists of medicines to treat gynaecological diseases, cardiovascular diseases, gastrointestinal diseases and central nervous system disorders. Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and markets a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. Key operational heads A list of personnel heading key departments/functions. Executive biographies A brief summary of the executives employment history. Key employees A list of the key executives of the company. Key competitors A list of key competitors to the company. Major products and services A list of major products, services and brands of the company. Company history Progression of key events associated with the company. SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats. Corporate strategy Analysts summarization of the companys business strategy. Business description A detailed description of the companys operations and business divisions. The profile contains critical company information including: ![]() The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |